Parametric Portfolio Associates’s Avenue Therapeutics ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-9
Closed -$26K – 3675
2021
Q2
$26K Sell
9
-14
-61% -$69.1K ﹤0.01% 3555
2021
Q1
$157K Sell
23
-2
-8% -$13.7K ﹤0.01% 3918
2020
Q4
$165K Buy
+25
New +$131K ﹤0.01% 3817

Other funds holding ATXI

Parametric Portfolio Associates's ATXI Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Avenue Therapeutics (ATXI) in Q3 2021, closing a stake of 9 shares — an estimated $26K sold.

Parametric Portfolio Associates first reported a position in ATXI in Q4 2020 and held it in 3 quarters. The position peaked at $165K in Q4 2020. 17 funds tracked by Wall St. Rank hold ATXI as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Avenue Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 9 Avenue Therapeutics shares in Q3 2021, an estimated $26K.
  • Parametric Portfolio Associates first reported a position in Avenue Therapeutics in Q4 2020 and held it in 3 quarters.
  • Parametric Portfolio Associates's Avenue Therapeutics position peaked at $165K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.